Carregant...
Varenicline Ameliorates Nicotine Withdrawal-Induced Learning Deficits in C57BL/6 Mice
Varenicline a partial agonist for α4β2 nicotinic acetylcholine receptors (nAChRs) and full agonist for α7 nAChRs, has been approved for the treatment of smoking cessation. While recent clinical trials support the efficacy of varenicline for managing global nicotine withdrawal symptoms and for smokin...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2683368/ https://ncbi.nlm.nih.gov/pubmed/18823172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1037/a0012601 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|